Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Orexin 1 receptor antagonists in compulsive behavior and anxiety: possible therapeutic use
Emilio Merlo Pich, Sergio Melotto
Frontiers in Neuroscience (2014) Vol. 8
Open Access | Times Cited: 57

Showing 26-50 of 57 citing articles:

Synthesis of [11C]MK-1064 as a new PET radioligand for imaging of orexin-2 receptor
Mingzhang Gao, Min Wang, Qi-Huang Zheng
Bioorganic & Medicinal Chemistry Letters (2016) Vol. 26, Iss. 15, pp. 3694-3699
Open Access | Times Cited: 19
Involvement of the orexin/hypocretin system in the pharmacological effects induced by Δ9‐tetrahydrocannabinol
África Flores, Marina Julià‐Hernández, Rafaël Maldonado, et al.
British Journal of Pharmacology (2016) Vol. 173, Iss. 8, pp. 1381-1392
Open Access | Times Cited: 18
The Effect of Orexin Receptor Antagonism on Quinpirole-Induced Compulsive-Like Checking Behavior in Rats
Mahdi Abounoori, Mohammad Moein Maddah, Esmaeil Akbari, et al.
Neurotoxicity Research (2020) Vol. 38, Iss. 1, pp. 18-26
Closed Access | Times Cited: 16
Role of medial hypothalamic orexin system in panic, phobia and hypertension
Aline Rezende Abreu, Andrei I. Molosh, Philip L. Johnson, et al.
Brain Research (2018) Vol. 1731, pp. 145942-145942
Open Access | Times Cited: 18
Unravelling the role and mechanism of adipokine and gastrointestinal signals in animal models in the nonhomeostatic control of energy homeostasis: Implications for binge eating disorder
Marta G. Novelle, Carlos Diéguez
European Eating Disorders Review (2018) Vol. 26, Iss. 6, pp. 551-568
Closed Access | Times Cited: 18
Discovery of ORN0829, a potent dual orexin 1/2 receptor antagonist for the treatment of insomnia
Aya Futamura, Ryo Suzuki, Yunoshin Tamura, et al.
Bioorganic & Medicinal Chemistry (2020) Vol. 28, Iss. 13, pp. 115489-115489
Closed Access | Times Cited: 15
Different Molecular/Behavioral Endophenotypes in C57BL/6J Mice Predict the Impact of OX1 Receptor Blockade on Binge-Like Ethanol Intake
Manuel Alcaráz-Iborra, Francisco Navarrete, Elisa Rodríguez‐Ortega, et al.
Frontiers in Behavioral Neuroscience (2017) Vol. 11
Open Access | Times Cited: 15
Small-molecule Antagonists of the Orexin Receptors
J.A. Christopher
Pharmaceutical Patent Analyst (2014) Vol. 3, Iss. 6, pp. 625-638
Closed Access | Times Cited: 12
Identification and Characterization of Cannabidiol as an OX1R Antagonist by Computational and In Vitro Functional Validation
Rosa Maria Vitale, Fabio Arturo Iannotti, Aniello Schiano Moriello, et al.
Biomolecules (2021) Vol. 11, Iss. 8, pp. 1134-1134
Open Access | Times Cited: 11
Identification of highly selective and potent orexin receptor 1 antagonists derived from a dual orexin receptor 1/2 antagonist based on the structural framework of pyrazoylethylbenzamide
Aya Futamura, Dai Nozawa, Yuko Araki, et al.
Bioorganic & Medicinal Chemistry (2017) Vol. 25, Iss. 20, pp. 5203-5215
Closed Access | Times Cited: 12
Blockade of orexin receptors attenuates the cardiovascular response to air-jet stress in spontaneously hypertensive rats
Éric Martin, Morgan E. Hernandez, Linda F. Hayward
Autonomic Neuroscience (2016) Vol. 201, pp. 8-16
Closed Access | Times Cited: 10
Environmental Enrichment During Adulthood Reduces Sucrose Binge-Like Intake in a High Drinking in the Dark Phenotype (HD) in C57BL/6J Mice
Elisa Rodríguez‐Ortega, Manuel Alcaráz-Iborra, Leticia de la Fuente, et al.
Frontiers in Behavioral Neuroscience (2019) Vol. 13
Open Access | Times Cited: 10
Oxadiazole Derivatives as Dual Orexin Receptor Antagonists: Synthesis, Structure–Activity Relationships, and Sleep‐Promoting Properties in Rats
Christine Brotschi, Catherine Roch, John Gatfield, et al.
ChemMedChem (2019) Vol. 14, Iss. 13, pp. 1257-1270
Closed Access | Times Cited: 10
Discovery and optimisation of 1-acyl-2-benzylpyrrolidines as potent dual orexin receptor antagonists
Jodi T. Williams, John Gatfield, Catherine Roch, et al.
MedChemComm (2015) Vol. 6, Iss. 6, pp. 1054-1064
Closed Access | Times Cited: 9
Orexin/Hypocretin System Dysfunction in ESSENCE (Early Symptomatic Syndromes Eliciting Neurodevelopmental Clinical Examinations)
Rajna Knez, Dejan Stevanović, Elisabeth Fernell, et al.
Neuropsychiatric Disease and Treatment (2022) Vol. Volume 18, pp. 2683-2702
Open Access | Times Cited: 6
Effect of nivasorexant (ACT‐539313), a selective orexin‐1‐receptor antagonist, on multiple cytochrome P450 probe substrates in vitro and in vivo using a cocktail approach in healthy subjects
Benjamin Berger, Priska Kaufmann, Matthias Berse, et al.
Pharmacology Research & Perspectives (2023) Vol. 11, Iss. 5
Open Access | Times Cited: 3
Essential structure of orexin 1 receptor antagonist YNT-707, Part IV: The role of D-ring in 4,5-epoxymorphinan on the orexin 1 receptor antagonistic activity
Tsuyoshi Saitoh, Kazunori Seki, Ryo Nakajima, et al.
Bioorganic & Medicinal Chemistry Letters (2019) Vol. 29, Iss. 18, pp. 2655-2658
Closed Access | Times Cited: 9
Orexin 1 and 2 Receptors in the Prelimbic Cortex Modulate Threat Valuation
Victor P. M. N. Soares, Telma Gonçalves Carneiro Spera de Andrade, Newton S. Canteras, et al.
Neuroscience (2021) Vol. 468, pp. 158-167
Closed Access | Times Cited: 7
From Oxadiazole to Triazole Analogues: Optimization toward a Dual Orexin Receptor Antagonist with Improved in vivo Efficacy in Dogs
Christine Brotschi, Martin H. Bolli, John Gatfield, et al.
ChemMedChem (2020) Vol. 15, Iss. 5, pp. 430-448
Closed Access | Times Cited: 6
Evaluation of the relationship between the gene expression level of orexin-1 receptor in the rat blood and prefrontal cortex, novelty-seeking, and proneness to methamphetamine dependence: A candidate biomarker
Mahnoosh Tavakkolifard, Nasim Vousooghi, Sara Mahboubi, et al.
Peptides (2020) Vol. 131, pp. 170368-170368
Closed Access | Times Cited: 6
Essential structure of orexin 1 receptor antagonist YNT-707: Conversion of the 16-cyclopropylmethyl group to the 16-sulfonamide group in d-nor-nalfurafine derivatives
Koki Katoh, Noriki Kutsumura, Naoshi Yamamoto, et al.
Bioorganic & Medicinal Chemistry Letters (2022) Vol. 59, pp. 128550-128550
Open Access | Times Cited: 4
Orexin A prevents degradation of the articular matrixes in human primary chondrocyte culture
Dong Wang, Hui Ren, Chunlong Li, et al.
Molecular Immunology (2018) Vol. 101, pp. 102-107
Closed Access | Times Cited: 5
Essential structure of orexin 1 receptor antagonist YNT-707, part V: Structure-activity relationship study of the substituents on the 17-amino group
Tsuyoshi Saitoh, Kazunori Seki, Ryo Nakajima, et al.
Bioorganic & Medicinal Chemistry Letters (2019) Vol. 30, Iss. 3, pp. 126893-126893
Closed Access | Times Cited: 5
Opportunities and perspectives for developing orexin receptor antagonists
Michel A. Steiner, Christopher J. Winrow
Frontiers in Neuroscience (2014) Vol. 8
Open Access | Times Cited: 4
DLK1 Expressed in Mouse Orexin Neurons Modulates Anxio-Depressive Behavior but Not Energy Balance
Tatiyana Harris, Raluca Bugescu, Jaylyn R. Kelly, et al.
Brain Sciences (2020) Vol. 10, Iss. 12, pp. 975-975
Open Access | Times Cited: 4

Scroll to top